{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:50:14Z","timestamp":1792086614548,"version":"4.4.0"},"reference-count":28,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:00:00Z","timestamp":1792022400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Coronary microvascular dysfunction (CMD) is a complication of severe aortic stenosis. Its prevalence after transcatheter aortic valve implantation (TAVI) and prognostic significance are understudied, as are the post-TAVI trajectories of microvascular indices.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>The aims of this study were to determine the pooled prevalence of CMD, the influence of the diagnostic modality, the post-TAVI coronary flow reserve (CFR) and microvascular resistance changes, and the prognostic impact of baseline CMD on major adverse cardiovascular events (MACE) in patients with severe aortic stenosis undergoing TAVI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Five databases were searched from January 2010 to December 2025 for studies involving adults with severe aortic stenosis undergoing TAVI in which CMD was assessed by wire-based thermodilution, angiography-derived indices, Doppler measurements, or stress cardiac magnetic resonance. The risk of bias and certainty of evidence were assessed using the Newcastle\u2013Ottawa Scale and GRADE, respectively. Random-effects meta-analyses (DerSimonian\u2013Laird) pooled CMD prevalence (stratified by modality), CFR change (mean difference; before\u2013after design), and prognostic hazard ratios (HRs). Change in microvascular resistance was synthesized narratively. The protocol was prospectively registered (PROSPERO: CRD42025143775) and reported per the PRISMA 2020 guidance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Eleven primary studies were analyzed, 10 of which (n\u2009=\u20091,212) contributed to the prevalence analyses. An additional study (n\u2009=\u2009126) was included in the sensitivity analyses only. CMD prevalence was 46.8% (95% confidence interval [CI] [34.0, 59.9]; I\n                      <jats:sup>2<\/jats:sup>\n                      \u2009=\u200972%) and 38.4% (95% CI [35.3, 41.7]; I\n                      <jats:sup>2<\/jats:sup>\n                      \u2009=\u20090%) when assessed using wire-based thermodilution (k\u2009=\u20096, n\u2009=\u2009324) and angiographic (k\u2009=\u20094, n\u2009=\u2009888) indices, respectively. CFR increased post-TAVI by a pooled mean difference of +0.49 (95% CI [+0.27,\u2009+\u20090.71]; I\n                      <jats:sup>2<\/jats:sup>\n                      \u2009=\u200972%; k\u2009=\u20095, n\u2009=\u2009103 paired observations). Reductions in microvascular resistance were confined to pressure-to-velocity and reserve ratio indices, and absolute minimal microvascular resistance was unchanged (k\u2009=\u20094, n\u2009=\u200985). The HR for MACE was 3.22 (95% CI [0.98, 10.60]; I\n                      <jats:sup>2<\/jats:sup>\n                      \u2009=\u200978%; k\u2009=\u20092, n\u2009=\u2009585). Substantial heterogeneity reflected non-equivalent CMD definitions.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec005\">\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The prevalence of CMD pre-TAVI is influenced by the diagnostic method. CFR tends to improve after TAVI, likely due to reduced resting demand rather than structural repair. The CMD\u2013MACE association should be viewed as hypothesis-generating due to limited studies, varied CMD definitions, and incompatible HR calculations. Prospective multicenter studies with standardized CMD definitions are required.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0360374","type":"journal-article","created":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:32:19Z","timestamp":1792085539000},"page":"e0360374","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Coronary microvascular dysfunction in patients undergoing transcatheter aortic valve implantation: A systematic review and meta-analysis"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-5995-4277","authenticated-orcid":true,"given":"Maethas","family":"Panyawongkhanti","sequence":"first","affiliation":[{"name":"Chulabhorn Royal Academy","place":["Bangkok, Thailand"],"department":["Princess Srisavangavadhana Faculty of Medicine"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-6687-9459","authenticated-orcid":true,"given":"Peerawat","family":"Chintrakulchai","sequence":"additional","affiliation":[{"name":"Chulabhorn Royal Academy","place":["Bangkok, Thailand"],"department":["Princess Srisavangavadhana Faculty of Medicine"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2702-2731","authenticated-orcid":true,"given":"Chonthicha","family":"Tanking","sequence":"additional","affiliation":[{"name":"Chulabhorn Hospital, Chulabhorn Royal Academy","place":["Bangkok, Thailand"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5691-0204","authenticated-orcid":true,"given":"Wongsakorn","family":"Luangphiphat","sequence":"additional","affiliation":[{"name":"Chulabhorn Royal Academy","place":["Bangkok, Thailand"],"department":["Princess Srisavangavadhana Faculty of Medicine"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,10,15]]},"reference":[{"issue":"7","key":"pone.0360374.ref001","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/eurheartj\/ehab395","article-title":"2021 ESC\/EACTS guidelines for the management of valvular heart disease","volume":"43","author":"A Vahanian","year":"2022","journal-title":"Eur Heart J"},{"issue":"8","key":"pone.0360374.ref002","article-title":"Coronary microcirculation in aortic stenosis: A physiological hornets\u2019 nest","volume":"12","author":"HZR McConkey","year":"2019","journal-title":"Circ Cardiovasc Interv"},{"issue":"21","key":"pone.0360374.ref003","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1016\/j.jacc.2018.09.042","article-title":"Coronary microvascular disease pathogenic mechanisms and therapeutic options","volume":"72","author":"VR Taqueti","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"pone.0360374.ref004","doi-asserted-by":"crossref","DOI":"10.4244\/EIJ-D-23-00735","article-title":"Characterisation of coronary microvascular dysfunction in patients with severe aortic stenosis undergoing TAVI","volume":"20","author":"R Scarsini","year":"2024","journal-title":"EuroIntervention"},{"issue":"8","key":"pone.0360374.ref005","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1136\/heartjnl-2023-323461","article-title":"Coronary microvascular dysfunction in patients undergoing transcatheter aortic valve implantation","volume":"110","author":"R Scarsini","year":"2024","journal-title":"Heart"},{"issue":"5","key":"pone.0360374.ref006","article-title":"Angiographic microvascular resistance is an independent predictor of adverse clinical outcomes after transcatheter aortic valve replacement","volume":"14","author":"W Shi","year":"2025","journal-title":"J Am Heart Assoc"},{"issue":"10","key":"pone.0360374.ref007","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.123.013185","article-title":"Integrated assessment of computational coronary physiology from a single angiographic view in patients undergoing TAVI","volume":"16","author":"S Fezzi","year":"2023","journal-title":"Circ Cardiovasc Interv"},{"key":"pone.0360374.ref008","doi-asserted-by":"crossref","first-page":"133263","DOI":"10.1016\/j.ijcard.2025.133263","article-title":"Management of TAVR in asymptomatic or minimally symptomatic patients: Insights from resting angiographic microvascular resistance","volume":"432","author":"W Shi","year":"2025","journal-title":"Int J Cardiol"},{"issue":"2","key":"pone.0360374.ref009","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jcin.2024.10.024","article-title":"Coronary physiological indexes to evaluate myocardial ischemia in patients with aortic stenosis undergoing valve replacement","volume":"18","author":"L Minten","year":"2025","journal-title":"JACC Cardiovasc Interv"},{"issue":"8","key":"pone.0360374.ref010","article-title":"Impact of aortic valve stenosis on coronary hemodynamics and the instantaneous effect of transcatheter aortic valve implantation","volume":"8","author":"EMA Wiegerinck","year":"2015","journal-title":"Circ Cardiovasc Interv"},{"key":"pone.0360374.ref011","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.amjcard.2024.01.005","article-title":"Coronary flow reserve and myocardial resistance reserve changes after transcatheter aortic valve implantation in aortic stenosis","volume":"214","author":"A Guti\u00e9rrez-Barrios","year":"2024","journal-title":"Am J Cardiol"},{"issue":"14","key":"pone.0360374.ref012","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.4244\/EIJ-D-22-00621","article-title":"Long-term changes in coronary physiology after aortic valve replacement","volume":"18","author":"M Sabbah","year":"2023","journal-title":"EuroIntervention"},{"issue":"14","key":"pone.0360374.ref013","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.4244\/EIJ-E-22-00052","article-title":"Understanding the mechanism of improved CFR after TAVR\/SAVR - the importance of basal flow","volume":"18","author":"MJ Kern","year":"2023","journal-title":"EuroIntervention"},{"key":"pone.0360374.ref014","article-title":"PRISMA 2020 explanation and elaboration: Updated guidance and exemplars for reporting systematic reviews","author":"MJ Page","year":"2021","journal-title":"BMJ"},{"key":"pone.0360374.ref015","volume-title":"The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses","author":"GA Wells"},{"issue":"7650","key":"pone.0360374.ref016","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"GH Guyatt","year":"2008","journal-title":"BMJ"},{"issue":"3","key":"pone.0360374.ref017","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"R DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"pone.0360374.ref018","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1471-2288-8-79","article-title":"Undue reliance on I(2) in assessing heterogeneity may mislead","volume":"8","author":"G R\u00fccker","year":"2008","journal-title":"BMC Med Res Methodol"},{"issue":"7414","key":"pone.0360374.ref019","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"JPT Higgins","year":"2003","journal-title":"BMJ"},{"issue":"19","key":"pone.0360374.ref020","doi-asserted-by":"crossref","DOI":"10.4244\/EIJ-D-24-00075","article-title":"Absolute coronary flow and microvascular resistance before and after transcatheter aortic valve implantation","volume":"20","author":"E Gallinoro","year":"2024","journal-title":"EuroIntervention"},{"issue":"6","key":"pone.0360374.ref021","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.124.014940","article-title":"Effect of TAVI on epicardial functional indices and their relationship to coronary microvascular function","volume":"18","author":"E Gallinoro","year":"2025","journal-title":"Circ Cardiovasc Interv"},{"issue":"2","key":"pone.0360374.ref022","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2025-003621","article-title":"Changes in myocardial blood flow and microvascular resistance in patients with coronary artery disease undergoing transcatheter aortic valve implantation","volume":"12","author":"E Yones","year":"2025","journal-title":"Open Heart"},{"issue":"10","key":"pone.0360374.ref023","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1136\/heartjnl-2022-321907","article-title":"Proof of concept study on coronary microvascular function in low flow low gradient aortic stenosis","volume":"109","author":"R Scarsini","year":"2023","journal-title":"Heart"},{"key":"pone.0360374.ref024","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"X Wan","year":"2014","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"pone.0360374.ref025","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1001\/jamacardio.2021.3396","article-title":"Association of myocardial blood flow reserve with adverse left ventricular remodeling in patients with aortic stenosis: The Microvascular Disease in Aortic Stenosis (MIDAS) study","volume":"7","author":"W Zhou","year":"2022","journal-title":"JAMA Cardiol"},{"issue":"11","key":"pone.0360374.ref026","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.033447","article-title":"Myocardial blood flow reserve, microvascular coronary health, and myocardial remodeling in patients with aortic stenosis","volume":"13","author":"F Alahdab","year":"2024","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"pone.0360374.ref027","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.123.013728","article-title":"Prognostic value of microvascular resistance reserve measured immediately after PCI in stable coronary artery disease","volume":"17","author":"T Nishi","year":"2024","journal-title":"Circ Cardiovasc Interv"},{"issue":"13","key":"pone.0360374.ref028","doi-asserted-by":"crossref","first-page":"4709","DOI":"10.3390\/jcm14134709","article-title":"Co-occurrence of aortic stenosis and coronary artery disease: Facing challenges before, during, and after transcatheter aortic valve replacement","volume":"14","author":"M Celeski","year":"2025","journal-title":"J Clin Med"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0360374","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:32:25Z","timestamp":1792085545000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0360374"}},"subtitle":[],"editor":[{"given":"Dhan Bahadur","family":"Shrestha","sequence":"first","affiliation":[{"name":"Mount Sinai Hospital","place":["UNITED STATES OF AMERICA"]}],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,10,15]]},"references-count":28,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10,15]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0360374","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,15]]}}}